GLENN H. NUSSDORF - 24 Nov 2025 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role: Director, 10%+ Owner
Signature: /s/ William R. Kolb, Attorney-in-Fact
Issuer symbol: ORGO
Transactions as of: 24 Nov 2025
Transactions value $: -$1,592,120
Form type: 4
Filing time: 26 Nov 2025, 18:24:24 UTC
Previous filing: 03 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
NUSSDORF GLENN H	Director, 10%+ Owner	35 SAWGRASS DRIVE, BELLPORT	/s/ William R. Kolb, Attorney-in-Fact	26 Nov 2025	0001244191

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORGO	Class A Common Stock	Sale	-$534K	-100K	-3.26%	$5.34	2.97M	24 Nov 2025	Direct	F1
transaction	ORGO	Class A Common Stock	Sale	-$63.8K	-12K	-0.41%	$5.30	2.95M	25 Nov 2025	Direct
transaction	ORGO	Class A Common Stock	Sale	-$994K	-188K	-6.36%	$5.29	2.77M	26 Nov 2025	Direct	F2
holding	ORGO	Class A Common Stock						919K	24 Nov 2025	By GN 2016 Family Trust u/a/d August 12, 2016
holding	ORGO	Class A Common Stock						7.93M	24 Nov 2025	By GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016
holding	ORGO	Class A Common Stock						336K	24 Nov 2025	By Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.40, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2	The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.39, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Content

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.40, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.39, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.